NFSG
TXG icon

Newbridge Financial Services Group’s 10x Genomics TXG Stock Holding History

Newbridge Financial Services Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,900
Closed -$444K – 1282
2026
Q1 		$444K Buy
+20,900
New +$418K 0.07% 154
2022
Q2 		– Sell
-175
Closed -$13K – 1525
2022
Q1 		$13K Buy
175
+65
+59% +$5.69K 0.01% 869
2021
Q4 		$16K Buy
+110
New +$16.8K 0.01% 796

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Newbridge Financial Services Group's TXG Position: Q2 2026 in Review

Newbridge Financial Services Group sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 20,900 shares — an estimated $444K sold.

Newbridge Financial Services Group first reported a position in TXG in Q4 2021 and held it in 3 quarters. The position peaked at $444K in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Newbridge Financial Services Group reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Newbridge Financial Services Group sold 20,900 10x Genomics shares in Q2 2026, an estimated $444K.
  • Newbridge Financial Services Group first reported a position in 10x Genomics in Q4 2021 and held it in 3 quarters.
  • Newbridge Financial Services Group's 10x Genomics position peaked at $444K in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.